- Home
- ALDX vs RWAY Comparison
ALDX vs RWAY Comparison
Compare ALDX & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- RWAY
- Stock Information
- Founded
- ALDX 2004
- RWAY 2015
- Country
- ALDX United States
- RWAY United States
- Employees
- ALDX N/A
- RWAY N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- RWAY
- Sector
- ALDX Health Care
- RWAY
- Exchange
- ALDX Nasdaq
- RWAY Nasdaq
- Market Cap
- ALDX 398.3M
- RWAY 395.5M
- IPO Year
- ALDX 2014
- RWAY 2021
- Fundamental
- Price
- ALDX $2.12
- RWAY $8.88
- Analyst Decision
- ALDX Strong Buy
- RWAY Buy
- Analyst Count
- ALDX 3
- RWAY 6
- Target Price
- ALDX $9.67
- RWAY $11.67
- AVG Volume (30 Days)
- ALDX 3.3M
- RWAY 570.2K
- Earning Date
- ALDX 05-01-2025
- RWAY 05-06-2025
- Dividend Yield
- ALDX N/A
- RWAY 13.57%
- EPS Growth
- ALDX N/A
- RWAY 73.09
- EPS
- ALDX N/A
- RWAY 1.89
- Revenue
- ALDX N/A
- RWAY $144,632,000.00
- Revenue This Year
- ALDX N/A
- RWAY N/A
- Revenue Next Year
- ALDX N/A
- RWAY N/A
- P/E Ratio
- ALDX N/A
- RWAY $4.71
- Revenue Growth
- ALDX N/A
- RWAY N/A
- 52 Week Low
- ALDX $1.14
- RWAY $8.35
- 52 Week High
- ALDX $7.20
- RWAY $13.50
- Technical
- Relative Strength Index (RSI)
- ALDX 26.33
- RWAY 30.12
- Support Level
- ALDX $1.79
- RWAY $8.51
- Resistance Level
- ALDX $2.32
- RWAY $9.44
- Average True Range (ATR)
- ALDX 0.49
- RWAY 0.42
- MACD
- ALDX -0.32
- RWAY -0.15
- Stochastic Oscillator
- ALDX 17.53
- RWAY 21.24
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.